1. Anti-diabetic effects of Protaetia brevitarsis in pancreatic islets and a murine diabetic model
- Author
-
Y M, Park, E-M, Noh, H Y, Lee, D Y, Shin, Y H, Lee, Y G, Kang, E-J, Na, J-H, Kim, H J, Yang, M J, Kim, K S, Kim, J S, Bae, and Y-R, Lee
- Subjects
Blood Glucose ,Male ,Biological Products ,Glucose Tolerance Test ,Nitric Oxide ,Diabetes Mellitus, Experimental ,Coleoptera ,Mice, Inbred C57BL ,Islets of Langerhans ,Mice ,Diabetes Mellitus, Type 2 ,Alloxan ,Animals ,Hypoglycemic Agents - Abstract
In this study, the antidiabetic efficacy of Protaetia brevitarsis in alloxan-treated pancreatic islets and db/db mice was investigated. P. brevitarsis was tested for alloxan-mediated cytotoxicity and nitric oxide production in mice pancreatic islets.The anti-diabetic effect of P. brevitarsis was also evaluated in db/db mice after 4 weeks of administration. Biochemical analysis, oral glucose tolerance test (OGTT), and pancreatic histological analysis were performed.P. brevitarsis displayed hypoglycemic activity in alloxan-treated mice pancreatic islets. Our results showed that P. brevitarsis protects pancreatic islets from cytotoxicity. Moreover, daily oral supplementation with P. brevitarsis for 4 weeks reduced plasma glucose levels without affecting body weight and food intake, elevated glucose tolerance in OGTT, improved blood lipid parameters, inhibited fat accumulation, and restored islet structure of db/db mice.The present study provided evidence for the anti‑diabetic effect of P. brevitarsis in alloxan-treated pancreatic islets and db/db mice. These results suggest that P. brevitarsis may be used as an adjunctive anti-diabetic agent or as a functional food.
- Published
- 2021